Sanofi India Limited (SANOFI) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.186x

Based on the latest financial reports, Sanofi India Limited (SANOFI) has a cash flow conversion efficiency ratio of 0.186x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.46 Billion ≈ $15.74 Million USD) by net assets (Rs7.82 Billion ≈ $84.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Sanofi India Limited - Cash Flow Conversion Efficiency Trend (2004–2025)

This chart illustrates how Sanofi India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Sanofi India Limited debt and liabilities for a breakdown of total debt and financial obligations.

Sanofi India Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sanofi India Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Ams AG
SW:AMS
0.120x
Xinjiang Yilite Industry Co Ltd
SHG:600197
-0.016x
Chongqing Constr Engineering
SHG:600939
-0.012x
Crystal Growth & Energy Equipment Co. Ltd. A
SHG:688478
N/A
Ningbo Tech-Bank Co Ltd
SHE:002124
0.051x
Power Mech Projects Limited
NSE:POWERMECH
0.087x
Jiangsu Rainbow Heavy Industries Co Ltd
SHE:002483
0.014x
Zhejiang Chunhui Intelligent Control Co. Ltd.
SHE:300943
-0.001x

Annual Cash Flow Conversion Efficiency for Sanofi India Limited (2004–2025)

The table below shows the annual cash flow conversion efficiency of Sanofi India Limited from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see SANOFI company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Rs7.49 Billion
≈ $81.02 Million
Rs4.51 Billion
≈ $48.76 Million
0.602x +12.23%
2024-12-31 Rs8.61 Billion
≈ $93.07 Million
Rs4.62 Billion
≈ $49.91 Million
0.536x +136.29%
2023-12-31 Rs10.15 Billion
≈ $109.79 Million
Rs2.30 Billion
≈ $24.92 Million
0.227x -27.38%
2022-12-31 Rs12.76 Billion
≈ $137.97 Million
Rs3.99 Billion
≈ $43.12 Million
0.313x +24.47%
2021-12-31 Rs22.26 Billion
≈ $240.69 Million
Rs5.59 Billion
≈ $60.43 Million
0.251x -12.94%
2020-12-31 Rs21.19 Billion
≈ $229.16 Million
Rs6.11 Billion
≈ $66.09 Million
0.288x +70.83%
2019-12-31 Rs24.42 Billion
≈ $264.13 Million
Rs4.12 Billion
≈ $44.59 Million
0.169x +0.20%
2018-12-31 Rs22.19 Billion
≈ $240.00 Million
Rs3.74 Billion
≈ $40.44 Million
0.168x -21.53%
2017-12-31 Rs20.26 Billion
≈ $219.15 Million
Rs4.35 Billion
≈ $47.05 Million
0.215x +15.52%
2016-12-31 Rs17.36 Billion
≈ $187.70 Million
Rs3.23 Billion
≈ $34.89 Million
0.186x +41.87%
2015-12-31 Rs16.27 Billion
≈ $175.97 Million
Rs2.13 Billion
≈ $23.05 Million
0.131x -26.53%
2014-12-31 Rs14.86 Billion
≈ $160.69 Million
Rs2.65 Billion
≈ $28.65 Million
0.178x -11.89%
2013-12-31 Rs13.47 Billion
≈ $145.64 Million
Rs2.73 Billion
≈ $29.48 Million
0.202x -14.90%
2012-12-31 Rs12.04 Billion
≈ $130.22 Million
Rs2.86 Billion
≈ $30.97 Million
0.238x +29.53%
2011-12-31 Rs11.17 Billion
≈ $120.76 Million
Rs2.05 Billion
≈ $22.17 Million
0.184x +42.45%
2010-12-31 Rs10.14 Billion
≈ $109.68 Million
Rs1.31 Billion
≈ $14.14 Million
0.129x -12.71%
2009-12-31 Rs9.32 Billion
≈ $100.77 Million
Rs1.38 Billion
≈ $14.88 Million
0.148x +2.28%
2008-12-31 Rs8.29 Billion
≈ $89.66 Million
Rs1.20 Billion
≈ $12.95 Million
0.144x -1.97%
2007-12-31 Rs7.07 Billion
≈ $76.44 Million
Rs1.04 Billion
≈ $11.26 Million
0.147x -27.73%
2006-12-31 Rs6.08 Billion
≈ $65.78 Million
Rs1.24 Billion
≈ $13.40 Million
0.204x -32.31%
2005-12-31 Rs5.24 Billion
≈ $56.65 Million
Rs1.58 Billion
≈ $17.05 Million
0.301x +77.53%
2004-12-31 Rs4.22 Billion
≈ $45.62 Million
Rs715.33 Million
≈ $7.74 Million
0.170x --

About Sanofi India Limited

NSE:SANOFI India Drug Manufacturers - General
Market Cap
$848.62 Million
Rs78.47 Billion INR
Market Cap Rank
#9863 Global
#464 in India
Share Price
Rs3407.20
Change (1 day)
-0.81%
52-Week Range
Rs3190.90 - Rs6377.00
All Time High
Rs10072.65
About

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, S… Read more